2015
DOI: 10.7324/japs.2015.50404
|View full text |Cite
|
Sign up to set email alerts
|

Development and Evaluation of Chitosan Based Polymeric Nanoparticles of an Antiulcer Drug Lansoprazole

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
21
0
1

Year Published

2016
2016
2024
2024

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 38 publications
(23 citation statements)
references
References 10 publications
1
21
0
1
Order By: Relevance
“…Entrapment efficiency was found to be dependent on the concentration of the chitosan so more entrapment efficiency was obtained with higher polymer concentration. The similar results were reported by Nagarajan et al, (2015) that entrapment efficiency of Lansoprazole loaded chitosan nanoparticles increased from 39.3±2.6% and 85.6±1.2% as the amount of chitosan increased 24 . Patil et al, (2014) formulated doxorubicin loaded spray dried chitosan nanocarriers and concluded that particles formed with maximum chitosan concentration resulted in increased entrapment efficiency 25 .…”
Section: Optimization Techniquesupporting
confidence: 79%
See 1 more Smart Citation
“…Entrapment efficiency was found to be dependent on the concentration of the chitosan so more entrapment efficiency was obtained with higher polymer concentration. The similar results were reported by Nagarajan et al, (2015) that entrapment efficiency of Lansoprazole loaded chitosan nanoparticles increased from 39.3±2.6% and 85.6±1.2% as the amount of chitosan increased 24 . Patil et al, (2014) formulated doxorubicin loaded spray dried chitosan nanocarriers and concluded that particles formed with maximum chitosan concentration resulted in increased entrapment efficiency 25 .…”
Section: Optimization Techniquesupporting
confidence: 79%
“…The release drug content was decreased with increase in chitosan concentration 24 .Sriramet al, (2013) studied that the results of the in-vitro dissolution studies of formulations F1 to F5 showed 94.92 % cumulative drug release at the end of 12 h while F5 formulation showed 78.67 % cumulative drug release at the end of 12 h. This is because with increase in polymer concentration the free drug concentration on the surface of microspheres will be decreased and more drug get entrapped in the microspheres and drug gets released slowly 26 .…”
Section: In-vitro Drug Release Studiesmentioning
confidence: 92%
“…21 Nanoparticles coated with the polysaccharide CS have attracted a special interest for mucoadhesive applications, mainly, because of its ability to interact with the negatively charged mucosal surface and to increase the absorption of drugs by reorganizing tight junctions (TJ) between mucosal cells. 22 Recently, the use of CS as surface coating for nanoparticle-medicated drug delivery in cancer was reported in many studies. 23,24 The objective of this study is to evaluate the potential of nanoformulation and surface coating with mucoadhesive CS to enhance bioavailability and reduce the possible systemic and local diarrheal side effect of DCN after oral administration.…”
Section: Introductionmentioning
confidence: 99%
“…Mucoadhesivity is a desired property for the delivery of drugs to mucosal tissues. Chitosan also has a very low toxicity [4]. …”
Section: Introductionmentioning
confidence: 99%